Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • hybrid nextera and truseq ends

    Hi,

    In an effort to utilize single-cell RNAseq, I'm following the general outline of SmartSeq2 (thank you Picelli et al!) but with a slightly modified workflow in order to incorporate Unique Molecular Identifiers and cell-specific barcodes. I'm basing my strategy on the bioRxiv manuscript from Soumillon et al (2014) which was then used by a comparative methods bioRxiv manuscript a few months ago. My central question is about the library prep stage, however.

    To the template-switch oligo, I've added UMI and cell-specific barcodes to the 3' end of the gene. I want to let the Nextera Tn5 add in the P7 adapter. But I redesigned the i5 adapter to add the P5 adapter sequence and also permit enrichment for the fragments that contain my UMI & barcode information. Since I do not have the final Nextera i5 sequences, I'm utilizing the TruSeq sequences. It's left me with an uncomfortably long i5 primer, but one that encodes P5, sequencing primer binding sequence, and a sequence to bring it all in.

    I've attached a schematic (see pdf). My questions are:

    1. Has anyone tried this strategy of a libraries with a Nextera end and a TruSeq end? Do you think the library prep step will succeed or will this fail during the enrichment PCR?

    2. Have I made a mistake in understanding how the Tn5 inserts sequences?

    3. Should I avoid the Tn5 and instead try something like NEBNext for library prep in order to make it easier to use a custom i5 primer?

    Thank you!

    Ramin
    Attached Files

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 06:25 AM
0 responses
13 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 01:02 PM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-18-2024, 06:39 AM
0 responses
14 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
14 views
0 likes
Last Post seqadmin  
Working...
X